Accelerate Diagnostics, Inc.
AXDX
$0.65
-$0.045-6.48%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -2.99% | -0.79% | 4.87% | -3.47% | -5.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.99% | -0.79% | 4.87% | -3.47% | -5.43% |
| Cost of Revenue | -5.42% | -2.43% | 19.67% | 8.93% | 0.63% |
| Gross Profit | 6.04% | 4.71% | -33.78% | -35.57% | -22.77% |
| SG&A Expenses | -31.69% | -34.17% | -28.98% | -30.55% | -20.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.87% | -27.78% | -18.57% | -20.23% | -12.53% |
| Operating Income | 34.64% | 33.44% | 23.32% | 23.58% | 13.98% |
| Income Before Tax | 17.53% | 16.07% | 53.46% | 11.68% | 2.88% |
| Income Tax Expenses | -107.76% | 168.57% | 779.75% | 1,205.19% | 1,205.19% |
| Earnings from Continuing Operations | 18.78% | 15.46% | 52.64% | 10.29% | 1.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.78% | 15.46% | 52.64% | 10.29% | 1.40% |
| EBIT | 34.64% | 33.44% | 23.32% | 23.58% | 13.98% |
| EBITDA | 37.19% | 35.82% | 25.04% | 25.05% | 15.10% |
| EPS Basic | 59.88% | 55.50% | 74.13% | 39.14% | 28.83% |
| Normalized Basic EPS | 49.39% | 72.45% | 64.47% | 51.48% | 44.27% |
| EPS Diluted | 59.89% | 55.54% | 74.15% | 39.21% | 28.87% |
| Normalized Diluted EPS | 49.39% | 72.45% | 64.47% | 51.48% | 44.27% |
| Average Basic Shares Outstanding | 85.35% | 81.62% | 81.44% | 64.99% | 51.75% |
| Average Diluted Shares Outstanding | 85.35% | 81.62% | 81.44% | 64.99% | 51.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
